Cover Image for Single-Cell vs Bulk RNA-Seq
Cover Image for Single-Cell vs Bulk RNA-Seq
27 Went

Single-Cell vs Bulk RNA-Seq

Hosted by Daniel Dacey, Eric Butcher & Mikal El Hajjar
Google Meet
Registration
Past Event
Welcome! To join the event, please register below.
About Event

Buzzed for Biotech & Dovetail Biopartners invite you to an interactive and in-depth 1.5-hour virtual webinar exploring single-cell versus bulk RNA sequencing—two powerful approaches advancing biotech research today. This event offers an engaging space for attendees to delve into the practical applications, challenges, and decision-making involved in choosing the optimal RNA sequencing technique for specific research goals.

What to Expect:

  • 30-Minute Primer on RNA-Seq Techniques:

    • A clear and accessible introduction to the principles behind single-cell and bulk RNA sequencing.

    • Exploration of real-world use cases that show how each technique can support preclinical and clinical research.

    • Insights into how these methods unlock different dimensions of biological data, from cell population dynamics to individual cellular diversity.

  • 1-Hour Audience-Driven, Open-Floor Discussion:

    • An opportunity for participants to actively engage in Q&A, idea-sharing, and brainstorming to get personalized insights on their RNA-seq challenges.

    • An interactive platform to ask questions, discuss challenges, and explore innovative solutions tailored to research needs across biotech and therapeutic development stages.

    • We expect most questions to revolve around experimental design and analytics, but feel free to ask about data management, cloud infrastructure, and ML/AI.

Led by Expert Mikal El-Hajjar

The discussion will be led by Dovetail Biopartners' Co-Founder and Director of Bioinformatics and Translational Biology, Mikal El-Hajjar, whose extensive experience in bioinformatics and translational research brings a unique perspective to the discussion.

  • About Mikal:

    • Holds a Master’s degree in Microbiology and Immunology, with practical experience spanning animal models, flow cytometry, and human data analysis.

    • In the final stages of her Ph.D. in experimental medicine at McGill University, focusing on idiopathic pulmonary fibrosis and employing bioinformatics tools like RNA-seq, single-cell RNA-seq, CHIP sequencing, and ATAC sequencing.

    • Bridges scientific research with real-world applications, driving innovation to support disease understanding and therapeutic discovery for Dovetail's clients.

Supported by Daniel Dacey and Eric Butcher.

So, whether you're a researcher designing experiments or someone interested in learning more about RNA sequencing, this session is crafted to help you make informed decisions on sequencing approaches. With each method offering unique insights—single-cell for detailed cellular heterogeneity and bulk RNA-seq for broader population analysis—we’ll help clarify the best applications of each.

Join us to learn, connect, and ensure your sequencing choices align with your research goals and budget!

About the Organizers:

Buzzed for Biotech
Your life science networking hub. We regularly put together events that facilitate rich discussions and connections across all areas of life sciences. Soon, we will have a networking app. Our primary goal with this app is to centralize event listings from all major sources, ensuring you never miss out on valuable networking and conference opportunities again. Our secondary goal is to have a space for people to connect outside of LinkedIn. Within the app, you can engage with other members on specific topics with ease.

Dovetail BioPartners
At Dovetail BioPartners, we accelerate actionable insights by delivering custom data solutions, combining expertise in translational biology with strategic advising services. We specialize in building cost-optimized cloud infrastructures, robust data pipelines, and bioinformatics/ML/AI processes—tailored to support research and development in the life sciences. Our work goes beyond just implementation; we empower you to fully understand your data, helping you make informed decisions to reach key milestones faster—whether it's FDA submission, securing funding, or forming strategic partnerships. All of this is offered with transparent, flat-fee pricing.

Reach out to Daniel Dacey to learn more about either!

27 Went